Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) shares saw unusually-strong trading volume on Friday . Approximately 149,046 shares changed hands during trading, a decline of 42% from the previous session's volume of 257,789 shares.The stock last traded at $62.10 and had previously closed at $61.05.
Semler Scientific Stock Down 6.6 %
The firm's 50-day moving average price is $35.84 and its 200 day moving average price is $31.98. The firm has a market cap of $472.70 million, a P/E ratio of 27.81 and a beta of 0.92.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million during the quarter.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. Sanctuary Advisors LLC acquired a new position in Semler Scientific during the 3rd quarter valued at about $104,000. Geode Capital Management LLC boosted its holdings in shares of Semler Scientific by 10.5% in the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company's stock valued at $3,202,000 after acquiring an additional 12,964 shares in the last quarter. Jane Street Group LLC increased its stake in shares of Semler Scientific by 72.3% during the third quarter. Jane Street Group LLC now owns 16,982 shares of the company's stock valued at $400,000 after acquiring an additional 7,126 shares during the period. State Street Corp raised its holdings in Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company's stock worth $2,784,000 after purchasing an additional 725 shares in the last quarter. Finally, Verition Fund Management LLC acquired a new stake in Semler Scientific in the third quarter worth approximately $251,000. Institutional investors and hedge funds own 49.37% of the company's stock.
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Recommended Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
